CILP1 as a biomarker for right ventricular dysfunction in patients with ischemic cardiomyopathy

The aim of this study was to evaluate the cartilage intermediate layer protein 1 (CILP1) as a biomarker of right ventricular dysfunction in patients with ischemic cardiomyopathy (ICM). CILP1 plasma concentrations were measured in 98 patients with ICM and 30 controls without any cardiac abnormalities...

Descripción completa

Detalles Bibliográficos
Autores principales: Keranov, Stanislav, Jafari, Leili, Haen, Saskia, Vietheer, Julia, Kriechbaum, Steffen, Dörr, Oliver, Liebetrau, Christoph, Troidl, Christian, Rutsatz, Wiebke, Rieth, Andreas, Hamm, Christian W., Nef, Holger, Rolf, Andreas, Keller, Till
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052998/
https://www.ncbi.nlm.nih.gov/pubmed/35506075
http://dx.doi.org/10.1002/pul2.12062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052998/
https://www.ncbi.nlm.nih.gov/pubmed/35506075
http://dx.doi.org/10.1002/pul2.12062

Ejemplares similares